Sep 15, 2021 / 05:25PM GMT
Jason Gerberry - BofA Global Research - Analyst
Good day, everybody. My name is Jason Gerberry, I'm one of the biopharmaceutical analysts here at Bank of America. I am pleased to be introducing our next company presenter, Viatris and CFO Sanjeev Narula. I'm going to hand the mic over to Bill Szablewski, Head of Capital Markets, who is going to read some legal disclaimers. And then we will jump into Q&A.
Bill Szablewski - Viatris Inc. - Head of Capital Markets
Thank you, Jason, and good afternoon, everybody. Just a quick disclaimer from the Company. During today's discussion, we may make forward-looking statements on a number of matters. These forward-looking statements are subject to risks and uncertainties that could cause future results or events to differ materially from today's projections.
Please refer to our SEC filings for a full explanation of these risks and uncertainties and the limits applicable to forward-looking statements. Also during today's discussion, we will not be providing any updates to our 2021 guidance or discussing Q3 2021 or
Viatris Inc at Bank of America Global Healthcare Conference (Virtual) Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers